Dr. Regis B. Kelly is the Director of QB3, one of four California Institutes for Science and Innovation,
created by the California Legislature to strengthen the academic foundation of its technology-
based industries. Scientists on the three QB3 campuses (UCB, UCSC & UCSF) working at the interface of
the physical and biological sciences. The QB3 innovation team converts discoveries into practical benefits
for society. As Director, Dr. Kelly helped launch two QB3-associated companies, QB3@953, a Life Sciences Startup
incubator and Mission Bay Capital, a venture fund. As a result of his experiences, Dr. Kelly was appointed as
Senior Advisor on Innovation and Entrepreneurship to the President of the University, Janet Napolitano.
Prior to joining QB3 in 2004, Regis Kelly served as executive vice-chancellor at UCSF and Chairman
of the Department of Biochemistry and Biophysics. He holds the inaugural Byers Family Distinguished
Professorship. His academic research was in the field of molecular and cellular neurobiology.
His training was at Harvard, Stanford, Caltech and the University of Edinburgh.
He has served on many national and international boards. In 2014 he was appointed an officer of the
Order of the British Empire (OBE) for services to science, innovation, and global health.